Chlorambucil | m-entrepreneurship.com

Product Name :
Chlorambucil

Search keywords :
Chlorambucil

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
DNA synthesis inhibitors

First Approval Country :
United States

First Approval Date Filter:
1957

Origin Company_Name :
Aspen Pharma

Active Company_Name :
Waylis Therapeutics LLC

Active Indication_Name:
Multiple Myeloma

In Active Indication_Name:
Leukemia, Lymphoid

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Evolocumab custom synthesis
Lemzoparlimab manufacturer
Methylmalonyl Coenzyme A mutase Antibody: Methylmalonyl Coenzyme A mutase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Methylmalonyl Coenzyme A mutase. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts